Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikhail Raevskiy

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Biochemistry. Biokhimiia|December 15, 2021
EGFR Pathway-Based Gene Signatures of Druggable Gene Mutations in Melanoma, Breast, Lung, and Thyroid CancersMikhail Raevskiy, Maxim Sorokin, Uliana Vladimirova, et al.
Cells|August 26, 2023
Human Blood Serum Can Diminish EGFR-Targeted Inhibition of Squamous Carcinoma Cell Growth through Reactivation of MAPK and EGFR PathwaysDmitri Kamashev, Nina Shaban, Timofey Lebedev, et al.
Cancers|July 24, 2021
Large-Scale Transcriptomics-Driven Approach Revealed Overexpression of <i>CRNDE</i> as a Poor Survival Prognosis Biomarker in GlioblastomaMaxim Sorokin, Mikhail Raevskiy, Alja Zottel, et al.
Frontiers in Oncology|May 3, 2021
Machine Learning Applicability for Classification of PAD/VCD Chemotherapy Response Using 53 Multiple Myeloma RNA Sequencing ProfilesNicolas Borisov, Anna Sergeeva, Maria Suntsova, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Biochemistry. Biokhimiia|December 15, 2021
EGFR Pathway-Based Gene Signatures of Druggable Gene Mutations in Melanoma, Breast, Lung, and Thyroid CancersMikhail Raevskiy, Maxim Sorokin, Uliana Vladimirova, et al.
Cells|August 26, 2023
Human Blood Serum Can Diminish EGFR-Targeted Inhibition of Squamous Carcinoma Cell Growth through Reactivation of MAPK and EGFR PathwaysDmitri Kamashev, Nina Shaban, Timofey Lebedev, et al.
Cancers|July 24, 2021
Large-Scale Transcriptomics-Driven Approach Revealed Overexpression of <i>CRNDE</i> as a Poor Survival Prognosis Biomarker in GlioblastomaMaxim Sorokin, Mikhail Raevskiy, Alja Zottel, et al.
Frontiers in Oncology|May 3, 2021
Machine Learning Applicability for Classification of PAD/VCD Chemotherapy Response Using 53 Multiple Myeloma RNA Sequencing ProfilesNicolas Borisov, Anna Sergeeva, Maria Suntsova, et al.
Pageof 2